Gliempaflozin 25 Tablet 10

Gliempaflozin 25 Tablet 10 is not recommended if you are pregnant. It may harm the unborn child. Consult your doctor for alternative treatment options.

Use Gliempaflozin 25 Tablet 10 with caution while breastfeeding. It is not known whether empagliflozin passes into breast milk.

Alcohol consumption can increase the risk of low blood sugar (hypoglycaemia) and dehydration. Avoid excessive intake while on Gliempaflozin 25 Tablet 10.

Patients with severe liver impairment should use Gliempaflozin 25 Tablet 10 cautiously, as dose adjustments or alternative medicines may be required.

Kidney function should be assessed before and during treatment. In severe kidney disease, your doctor may recommend a lower dose or discontinuation.

Gliempaflozin 25 Tablet 10 may cause dizziness, especially if taken with insulin or sulphonylureas that lower blood sugar. Avoid driving or operating heavy machinery if you feel unwell.

Do not take Gliempaflozin 25 Tablet 10 if you are allergic to empagliflozin or any other ingredient in the formulation. Report symptoms such as rash, swelling, or difficulty breathing immediately.

Gliempaflozin 25 Tablet 10 can be used in children aged 10 years and above with type 2 diabetes. It is not recommended for younger children.

Elderly patients, particularly those aged over 75 years, may have a higher risk of dehydration. Regular monitoring is advised.